COMMUNIQUÉS West-GlobeNewswire

Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
06/10/2026
ORION CORPORATION PRESS RELEASE 6 OCTOBER 2026 at 9.00 EEST Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market Orion Corporation (“Orion Pharma”) and Qilu Pharma [...]
Bulk Peptides: Kylo Peptides Launches Bulk Research Program for High-Volume Laboratories
06/10/2026
Sheridan, Wyoming, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com/ ] has introduced a research program that supplies bulk peptides to laboratories with higher-volume peptide requirements. It [...]
Kylo Peptides Review Brings Transparency to the Research Peptide Market
06/10/2026
Review highlights testing documentation, lot-specific COAs, independent laboratory analysis, and supplier information to help researchers evaluate research peptide sources. Sheridan, Wyoming, Oct. 06, 2026 (GLOBE [...]
Press Release : Availability of the aide-mémoire for Q3 2026 results
06/10/2026
Availability of the aide-mémoire for Q3 2026 results Paris, France – October 6, 2026 . Sanofi announced today the availability of the aide-mémoire for Q3 2026 results on the "Investors" page of sanofi.com: Third quarter [...]
Communiqué de presse : Mise en ligne du document «Q3 2026 aide-mémoire »
06/10/2026
Mise en ligne du document «Q3 2026 aide-mémoire » Paris, France – 6 octobre 2026 . Sanofi annonce la mise en ligne de son « Q3 2026 aide-mémoire » sur la page « Investisseurs » de sanofi.com. Résultats du troisième [...]
Nox Peptides Announces Expanded Research Focus on BPC-157 as Canadian Peptide Research Supply Demand Grows
06/10/2026
Toronto, ON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Nox Peptides today announced an expanded focus on providing information and access to research peptide supplies for Canadian laboratories, academic researchers and [...]
Peptides Canada Operated by Growth Guys Announces Launch of Domestic Research Peptide Supply Platform
06/10/2026
TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Peptides Canada , operated by Growth Guys, today announced the launch of its Canadian research-peptide supply platform , providing a domestic online source for peptide [...]
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock
06/10/2026
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate [...]
Legacy Opens Acres Homes Clinic to Expand Access to Care in a Historic Houston Community
06/10/2026
New 26,200-square-foot clinic brings coordinated, affordable care under one roof for Acres Homes families Legacy Community Health, Houston Methodist, elected officials and community leaders celebrate the grand opening [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/10/2026
BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 1, 2026, the Compensation [...]
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
05/10/2026
SAN CARLOS, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that it has commenced underwritten public offerings of $500 million of its [...]
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
05/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
05/10/2026
Strengthens leadership team with appointments of John Brottem as general counsel and Amelia Merrill as chief people officer FREMONT, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR) a [...]
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
05/10/2026
MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2026 after the close of trading on Monday, November 2. Inspire’s [...]
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED
05/10/2026
BOSTON, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced it has entered into a definitive agreement to sell its Microfluidics business [...]
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
05/10/2026
Initiated a Phase 1/2 clinical trial to enroll healthy volunteers and patients with Urea Cycle Disorders of any mutational background Administered a single dose of 2mg/kg to the first cohort of healthy volunteers [...]
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
05/10/2026
On track to initiate dosing by early November 2026; topline Phase 1 proof-of-mechanism data anticipated approximately six months following study initiation Randomized, double-blind, placebo-controlled study will [...]
Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting
05/10/2026
IRVINE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featured at the upcoming American Society of Nephrology Kidney Week [...]
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
05/10/2026
WALTHAM, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate [...]

Pages